Cite

HARVARD Citation

    Bartoletti, M. et al. (2021). Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitors. Cancer treatment reviews. p. . [Online]. 
  
Back to record